Metastatic Colo-Rectal Cancer, 2005-2008: Treatment results
Introduction: Colo-rectal cancer has 10% prevalence, among all of the cancer proportionally and also it is the third common cancer in the both sexes. Two recently introduced active drugs in the treatment of advanced colorectal cancer (ACC) are irinotecan and oxaliplatin. The combinations of oxalipla...
Main Authors: | Mozaffar Aznab, A Tabarroki, Gh Mohsseni, F Farshian, K Kavyani |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2009-12-01
|
Series: | International Journal of Hematology-Oncology and Stem Cell Research |
Subjects: | |
Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/228 |
Similar Items
-
Metastatic Colo-Rectal Cancer, 2005-2008: Treatment results
by: Mozaffar Aznab, et al.
Published: (2009-10-01) -
Cáncer Colo-rectal
by: Germán Reyes, et al.
Published: (2022-04-01) -
Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on <i>RAS</i> Mutation
by: Shohei Udagawa, et al.
Published: (2023-02-01) -
Tumores carcinoides Colo-rectales
by: Germán Reyes, et al.
Published: (2022-06-01) -
Hepatic Resection in Patients with Colo-Rectal Liver Metastases: Surgical Outcomes and Prognostic Factors of Single-Center Experience
by: Matteo Pagani, et al.
Published: (2023-03-01)